We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAHC.U
376
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$751K 0.02%
+75,000
New +$751K
UP icon
377
Wheels Up
UP
$209M
$750K 0.02%
+375
New +$790K
WALDU
378
DELISTED
Waldencast Acquisition Corp. Units
WALDU
$749K 0.02%
+75,000
New +$753K
CPTK.U
379
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
$733K 0.02%
+73,733
New +$745K
OEPW
380
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
$732K 0.02%
+75,000
New +$732K
SQZ
381
DELISTED
SQZ Biotechnologies Company
SQZ
$707K 0.02%
+51,662
New +$1.05M
ZH
382
Zhihu
ZH
$279M
$691K 0.02%
+14,206
New +$683K
HMCOW
383
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$686K 0.02%
+527,660
New +$1.08M
AMED
384
DELISTED
Amedisys
AMED
$666K 0.01%
+2,516
New +$710K
FLME.U
385
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
$651K 0.01%
+65,562
New +$655K
BOAS.U
386
DELISTED
BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant
BOAS.U
$619K 0.01%
+62,500
New +$624K
RCLFU
387
DELISTED
Rosecliff Acquisition Corp I Unit
RCLFU
$600K 0.01%
+60,468
New +$608K
FOREU
388
DELISTED
Foresight Acquisition Corp. Units
FOREU
$595K 0.01%
+60,000
New +$608K
VOSO
389
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$562K 0.01%
+58,126
New +$565K
RETA
390
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$511K 0.01%
5,121
-67,976
-93% -$7.93M
ML
391
DELISTED
MoneyLion Inc.
ML
$507K 0.01%
+1,697
New +$566K
ASPCU
392
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
$501K 0.01%
+50,200
New +$511K
LCAAU
393
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
$498K 0.01%
+50,000
New +$500K
GLBLU
394
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$498K 0.01%
+50,000
New +$500K
VGII.U
395
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$497K 0.01%
+50,000
New +$498K
TWNI.U
396
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$495K 0.01%
+50,000
New +$504K
ABGI
397
DELISTED
ABG Acquisition Corp. I
ABGI
$440K 0.01%
+44,498
New +$447K
SNCY
398
DELISTED
Sun Country Airlines
SNCY
$425K 0.01%
+12,402
New +$421K
ORTX
399
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$409K 0.01%
5,630
-67,916
-92% -$4.82M
TARS icon
400
Tarsus Pharmaceuticals
TARS
$2.82B
$397K 0.01%
+12,310
New +$455K

Similar funds

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.